Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) Interest & Investment Income (2016 - 2025)

Nephros has reported Interest & Investment Income over the past 12 years, most recently at $54000.0 for Q4 2025.

  • Quarterly results put Interest & Investment Income at $54000.0 for Q4 2025, up 92.86% from a year ago — trailing twelve months through Dec 2025 was $139000.0 (up 47.87% YoY), and the annual figure for FY2025 was $139000.0, up 47.87%.
  • Interest & Investment Income for Q4 2025 was $54000.0 at Nephros, up from $41000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for NEPH hit a ceiling of $54000.0 in Q4 2025 and a floor of $1000.0 in Q2 2022.
  • Median Interest & Investment Income over the past 5 years was $12500.0 (2023), compared with a mean of $16050.0.
  • Biggest five-year swings in Interest & Investment Income: crashed 66.67% in 2022 and later surged 1200.0% in 2023.
  • Nephros' Interest & Investment Income stood at $2000.0 in 2021, then soared by 250.0% to $7000.0 in 2022, then soared by 300.0% to $28000.0 in 2023, then changed by 0.0% to $28000.0 in 2024, then skyrocketed by 92.86% to $54000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $54000.0 (Q4 2025), $41000.0 (Q3 2025), and $31000.0 (Q2 2025) per Business Quant data.